Risk of alanine transferase (ALT) elevation in patients with rheumatoid arthritis treated with methotrexate in a DAS-steered strategy

L. Dirven, N.B. Klarenbeek, M. van den Broek, J.H.L.M. Groenendael, P.B.J. de Sonnaville, P.J.S.M. Kerstens, T.W.J. Huizinga, B.A.C. Dijkmans, W.F. Lems, C.F. Allaart

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)585-590
JournalClinical Rheumatology
Issue number5
Publication statusPublished - 2013

Cite this